A phase-3 clinical trial studying the effects of Sutent (sunitinib) has been halted early as the drug is shown to be effective in treating advanced pancreatic islet cell tumors.

New research from Johns Hopkins University suggests why some people with a rare pancreatic cancer are able to live for a decade or longer from diagnosis.

A new study suggests efforts to determine the nutritional effect on Alzheimer's disease could be improved by using nutrient “biomarkers” in elderly people at risk for dementia.

Mammograms may be able to serve another purpose besides detecting breast cancer. The diagnostic tool has been shown to detect calcifications in the blood vessels of patients with advanced kidney disease.

A genetic test may be able to identify those with stage II colon cancer who face a higher risk of recurrence, according to new research from Germany.

Clinical trials under way at four cancer-treatment centers in the U.S. may revolutionize the way the second-leading cause of death in the U.S. is treated.

The American Diabetes Association (ADA) has awarded $600,000 to the Albert Einstein College of Medicine of Yeshiva University to study the effects of resveratrol on prediabetes.

Pharmaceutical company Novartis AG's multiple sclerosis (MS) drug, Gilenya, has been approved for use in the United States and now Europe to treat relapsing-remitting forms of the disease.

Glaucoma, a leading cause of blindness in the U.S., may not start in the optic nerve of the eye as previously believed. Researchers indicate the first sign of the disease may appear in the brain.

MIT researchers have discovered that endothelial cells (cells in blood vessels) secrete molecules that inhibit tumor growth and deter cancer cells' invasion of other tissues.